Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Video Credit: Wochit News
Published on May 23, 2020 - Duration: 00:25s

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.

He explained "According to the most likely scenario, we will not have a vaccination before the end of next year." Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.


You are here

Related news from verified sources

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 22, 2020 • Reuters India

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 23, 2020 • Reuters India

"The authors reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate."
on May 26, 2020 • DNA

Related videos from verified sources

Study focuses on risks of breast cancer after pre-invasive disease 01:12
Video credit: ANI - Published on May 29, 2020 

World Health Organization Halts Trials Of Hydroxychloroquine 00:38
Video credit: Wochit - Published on May 26, 2020 

Explained: Why WHO suspended hydroxychloroquine trials | Covid-19 05:09
Video credit: HT Digital Content - Published on May 26, 2020 

You might like